IL-18 upregulates TLR4 expression in PTCL cells, activating the downstream NF-κB-mediated anti-apoptotic pathway to promote tumor proliferation and chemoresistance. This evidence concerns the gene TLR4 and mature T-cell and NK-cell non-Hodgkin lymphoma.